SCHEMBL4283210

SCHEMBL4283210

Cc1cc(C)c(Cc2ccc(CCO)cc2)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ALOX5 P09917 1/20 0.47
GAA P10253 1/20 0.47
CA2 P00918 2/20 0.42
ALOX15 P16050 2/20 0.41
IGF1R P08069 1/20 0.41
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
SLC28A3 Q9HAS3 1/20 0.39
THRA P10827 3/20 0.38
THRB P10828 3/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
MAPK1 P28482 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6299900 0.84 THRA (0.49) ALOX15IGF1RESR1ESR2SLC28A3
SCHEMBL10986788 0.81 ESR1 (0.40) MAPTALDH1A1GAAALOX15IGF1R
SCHEMBL31154580 0.81 BCL2 (0.47) MAPTKDM4EALDH1A1ALOX5ALOX15
SCHEMBL3597203 0.79 PTGS1 (0.44) ALDH1A1GAAESR1ESR2THRA
SCHEMBL3998037 0.79 IDH1 (0.48) ALDH1A1ALOX5ALOX15IGF1RTHRA
SCHEMBL4284350 0.78 APP (0.40) MAPTALOX5CA2ALOX15IGF1R
SCHEMBL69436 0.78 SELL (0.48) BACE1MAPTKDM4EALDH1A1GAA
SCHEMBL3999649 0.75 CYP4F2 (0.35) CA2THRATHRBHPGDCYP4F2
SCHEMBL15799777 0.74 THRB (0.57) MAPTKDM4EALDH1A1GAAALOX15
SCHEMBL4000887 0.73 L3MBTL1 (0.52) MAPTALDH1A1ESR1ESR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 BACE1 2726/4885MAPT 2884/4885KDM4E 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.